These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 1180867)

  • 1. Immunoadjuvant activities of synthetic N-acetyl-muramyl-peptides or -amino acids.
    Kotani S; Watanabe Y; Kinoshita F; Shimono T; Morisaki I
    Biken J; 1975 Jun; 18(2):105-11. PubMed ID: 1180867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoadjuvant activities of cell walls, their water-soluble fractions and peptidoglycan subunits, prepared from various gram-positive bacteria, and of synthetic n-acetylmuramyl peptides.
    Kotani S; Watanabe Y; Shimono T; Narita T; Kato K
    Z Immunitatsforsch Exp Klin Immunol; 1975 Jul; 149(2-4):302-19. PubMed ID: 126564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoadjuvant activities of peptidoglycan subunits from the cell walls of Staphyloccus aureus and Lactobacillus plantarum.
    Kotani S; Watanabe Y; Shimono T; Kinoshita F; Narita T
    Biken J; 1975 Jun; 18(2):93-103. PubMed ID: 1180873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between the immunoadjuvant activities and pyrogenicities of synthetic N-acetylmuramyl-peptides or -amino acids.
    Kotani S; Watanabe Y; Shimono T; Harada K; Shiba T
    Biken J; 1976 Mar; 19(1):9-13. PubMed ID: 779765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of replacement of L-alanine residue by glycine, L-serine or D-alanine in an N-acetylmuramyl-L-alanyl-D-isoglutamine on immunoadjuvancies of molecules.
    Kotani S; Watanabe Y; Kinoshita F; Morisaki I; Kato K
    Biken J; 1977 Jun; 20(2):39-45. PubMed ID: 588232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoadjuvant activities of synthetic 6-O-acyl-N-acetylmuramyl-L-alanyl-D-isoglutamine with special reference to the effect of its administration with liposomes.
    Kotani S; Kinoshita F; Morisaki I; Shimono T; Okunaga T; Takada H; Tsujimoto M; Watanabe Y; Kato K; Shiba T; Kusumoto S; Okada S
    Biken J; 1977 Dec; 20(3-4):95-103. PubMed ID: 614856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptidoglycan adjuvants: minimal structure required for activity.
    Adam A; Ellouz F; Ciorbaru R; Petit JF; Lederer E
    Z Immunitatsforsch Exp Klin Immunol; 1975 Jul; 149(2-4):341-8. PubMed ID: 126566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical structure and biological activity relationship of bacterial cell walls and muramyl peptides.
    Kotani S; Tsujimoto M; Koga T; Nagao S; Tanaka A; Kawata S
    Fed Proc; 1986 Oct; 45(11):2534-40. PubMed ID: 3758371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant activity of 6-O-mycoloyl-N-acetylmuramuyl-L-alanyl-D-isoglutamine.
    Yamamura Y; Azuma I; Sugimura K; Yamawaki M; Uemiya M
    Gan; 1976 Dec; 67(6):867-77. PubMed ID: 828599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gelation of the amoebocyte lysate of Tachypleus tridentatus by cell wall digest of several gram-positive bacteria and synthetic peptidoglycan subunits of natural and unnatural configurations.
    Kotani S; Watanabe Y; Kinoshita F; Kato K; Harada K
    Biken J; 1977 Mar; 20(1):5-10. PubMed ID: 880206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoadjuvant effects of the synthetic muramyl-dipeptide (MDP) N-acetylmuramyl-L-alanyl-D-isoglutamine.
    Heymer B; Finger H; Wirsing CH
    Z Immunitatsforsch Immunobiol; 1978 Oct; 155(1):87-92. PubMed ID: 706536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute and chronic polyarthritis induced by an aqueous form of 6-O-acyl and N-acyl derivatives of N-acetylmuramyl-L-alanyl-D-isoglutamine in euthymic rats and athymic nude rats.
    Kohashi O; Kohashi Y; Shigematsu N; Ozawa A; Kotani S
    Lab Invest; 1986 Sep; 55(3):337-46. PubMed ID: 3489128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant activities in production of reaginic antibody by bacterial cell wall peptidoglycan or synthetic N-acetylmuramyl dipeptides in mice.
    Ohkuni H; Norose Y; Ohta M; Hayama M; Kimura Y; Tsujimoto M; Kotani S; Shiba T; Kusumoto S; Yokogawa K; Kawata S
    Infect Immun; 1979 May; 24(2):313-8. PubMed ID: 457277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inabilities as an immunoadjuvant of cell walls of the group B peptidoglycan types and those of arthrobacters.
    Kotani S; Watanabe Y; Kinoshita F; Kato K; Schleifer KH
    Biken J; 1977 Mar; 20(1):1-4. PubMed ID: 880204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant activity of some nonpyrogenic hydrophobic analogues of muramyl dipeptide in enhancing the primary humoral and cell mediated immune responses in guinea pig model.
    Saxena RP; Puri A; Saxena KC; Shukla R; Haq W; Rizvi SY; Kundu B; Mathur KB
    Indian J Exp Biol; 1991 Feb; 29(2):111-5. PubMed ID: 1869292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunoadjuvant activities of bacterial cell wall components--with special reference to the effects of administration with various vehicles].
    Kinoshita F
    Osaka Daigaku Shigaku Zasshi; 1978 Jun; 23(1):141-57. PubMed ID: 397324
    [No Abstract]   [Full Text] [Related]  

  • 17. Biological activity of synthetic subunits of streptococcus peptidoglycan. III. Relationship of subunit and analogue structure to adjuvant activity in cell-mediated immunity.
    Pekárek J; Rotta J; Zaoral M; Krchnák V; Straka R; Jezek J; Rýc M
    Exp Cell Biol; 1985; 53(5):260-4. PubMed ID: 4043505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between chemical structure and adjuvant activity of some synthetic analogues of N-acetyl-muramyl-L-alanyl-D-isoglutamine (MDP).
    Audibert F; Chedid L; Lefrancier P; Choay J; Lederer E
    Ann Immunol (Paris); 1977; 128C(3):653-61. PubMed ID: 869513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoadjuvant activities of cell walls and their water-soluble fractions prepared from various gram-positive bacteria.
    Kotani S; Narita T; Stewart-Tull DE; Shimono T; Watanabe Y
    Biken J; 1975 Jun; 18(2):77-92. PubMed ID: 1180872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of binding of MDP, a synthetic immunoadjuvant, to anti-peptidoglycan antibodies.
    Audibert F; Heymer B; Gros C; Schleifer KH; Seidl PH; Chedid L
    J Immunol; 1978 Oct; 121(4):1219-22. PubMed ID: 701793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.